LabGenius, which uses machine learning (ML) for antibody discovery, has presented data in a poster presentation at the Protein Engineering and Biotherapeutics (PEGS) annual meeting.
Labgenius is an England-based drug discovery company that researches and develops novel therapeutic antibodies for the treatment of cancer and inflammatory diseases.